Clinical Trial Update: Evaluate the Efficacy and Safety of Xianglei Tangzu Gao for the Treatment of Wagner Grade II Diabetic Foot Ulcers [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update states that Oneness Biotech is recruiting for Phase 2 and Phase 3 studies evaluating Xianglei Tangzu Gao for Wagner Grade II diabetic fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Xianglei Tangzu Gao

Snippet

Sponsor: Oneness Biotech Co., Ltd. | Conditions: Diabetic Foot Ulcer | Phase 2, Phase 3 | Status: RECRUITING